Charles L. Sprung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Charles L. Sprung has a total of 320 co-authors. Here are the top co-authors by number of shared publications:
- Michael D. Christian
Faculty of Medicine, Department of Critical Care Medicine, University of British Columbia, Vancouver, Canada
6 shared publications Alexander Avidan
Department of Anesthesiology, Critical Care, and Pain Medicine, Hadassah Ein Karem Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
4 shared publications- Gavin Matthew Joynt
Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Hong Kong SAR, China
4 shared publications Mario Baras
The Hebrew University—Hadassah School of Public Health, Jerusalem, Israel
4 shared publicationsRobert Cohen
Hebrew University Faculty of Medicine, Medical Education, Jerusalem, Israel
4 shared publications- Alexander Avidan
Department of Anesthesiology, Critical Care and Pain Medicine, Hadassah Medical Organization and Hebrew University of Jerusalem, Faculty of Medicine, Jerusalem, Israel
3 shared publications
Latest Publications
- Open Access
- 16 March 2026
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 54 (4) , 701-714
Influence of Age in End-of-Life Practices in Worldwide ICUs (ETHICUS-2): A Prospective Observational Study
OBJECTIVES: The practice of limiting life-sustaining therapy (LST) at end-of-life is widespread globally. The goal of this study was to evaluate whether patient’s age influences end-of-life limitations overall and of various LST in ICUs worldwide. DESIGN: Multinational, multicenter, prospective observational study. SETTING: One hundred ninety-nine ICUs in 36 countries worldwide. PATIENTS: Consecutive adult patients admitted to ICUs who died and/or had LST limitations (withholding, withdrawing, or active shortening of the dying process) were included during a 6-month period between September 2015 and September 2016. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Patients were grouped: younger than 65 years, 65–79 years old, and 80 years old or older. A total of 12,200 patients were included. In multivariate logistic regression analysis, odds ratio (OR) for any LST limitation in the 80 years old or older group was higher than in younger than the 65 years old group (OR 1.47 [95% CI, 1.22–1.76], p < 0.001). When stratified by region, this association was significant in Central and Southern Europe (OR 1.56 [95% CI, 1.11–2.20], p = 0.037 and OR 2.23 [95% CI, 1.58–3.17], p < 0.001, respectively), but not in the other regions. The proportion of withholding therapy of each LST was highest in the group of individuals 80 years or older, whereas the proportion of withdrawing therapy was highest in the group younger than 65 years. The 80-year-old or older group also had a shorter time from ICU admission to first limitation. The predominant reason for any LST limitation in all age groups was unresponsiveness to maximal therapy, followed by neurologic and chronic diseases. Patient age was rarely the primary reason for limitations for all groups. CONCLUSIONS: End-of-life limitations were higher in patients 80 years or older compared to those 65 years old or younger, with regional variations. The main reasons for limitations were comparable across age groups, with age not being the primary reason.
- 16 March 2026
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 54 (4) , 701-714
Open AccessInfluence of Age in End-of-Life Practices in Worldwide ICUs (ETHICUS-2): A Prospective Observational Study
OBJECTIVES: The practice of limiting life-sustaining therapy (LST) at end-of-life is widespread globally. The goal of this study was to evaluate whether patient’s age influences end-of-life limitations overall and of various LST in ICUs worldwide. DESIGN: Multinational, multicenter, prospective observational study. SETTING: One hundred ninety-nine ICUs in 36 countries worldwide. PATIENTS: Consecutive adult patients admitted to ICUs who died and/or had LST limitations (withholding, withdrawing, or active shortening of the dying process) were included during a 6-month period between September 2015 and September 2016. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Patients were grouped: younger than 65 years, 65–79 years old, and 80 years old or older. A total of 12,200 patients were included. In multivariate logistic regression analysis, odds ratio (OR) for any LST limitation in the 80 years old or older group was higher than in younger than the 65 years old group (OR 1.47 [95% CI, 1.22–1.76], p < 0.001). When stratified by region, this association was significant in Central and Southern Europe (OR 1.56 [95% CI, 1.11–2.20], p = 0.037 and OR 2.23 [95% CI, 1.58–3.17], p < 0.001, respectively), but not in the other regions. The proportion of withholding therapy of each LST was highest in the group of individuals 80 years or older, whereas the proportion of withdrawing therapy was highest in the group younger than 65 years. The 80-year-old or older group also had a shorter time from ICU admission to first limitation. The predominant reason for any LST limitation in all age groups was unresponsiveness to maximal therapy, followed by neurologic and chronic diseases. Patient age was rarely the primary reason for limitations for all groups. CONCLUSIONS: End-of-life limitations were higher in patients 80 years or older compared to those 65 years old or younger, with regional variations. The main reasons for limitations were comparable across age groups, with age not being the primary reason.
- Open Access
- 3 June 2025
- Published by Springer Nature in Intensive Care Medicine
- Vol. 51 (6) , 1135-1138
REMAP-CAP corticosteroids: yet, another swing of the pendulum?
- 3 June 2025
- Published by Springer Nature in Intensive Care Medicine
- Vol. 51 (6) , 1135-1138
Open AccessREMAP-CAP corticosteroids: yet, another swing of the pendulum?
- 20 July 2023
- Published by Springer Nature
- p. 131-140
Clinical Ethics and the Law
- 20 July 2023
- Published by Springer Nature
- p. 81-94
Prinicples and Practice of Limiting Life-Sustaining Therapies
- 20 July 2023
- Published by Springer Nature
- p. 81-94
Prinicples and Practice of Limiting Life-Sustaining Therapies
- Open Access
- 16 June 2023
- Published by Elsevier in Clinical Nutrition Open Science
- Vol. 50, 16-26
Ethical considerations of medical nutritional therapy at end of life: the Israel perspective
- 16 June 2023
- Published by Elsevier in Clinical Nutrition Open Science
- Vol. 50, 16-26
Open AccessEthical considerations of medical nutritional therapy at end of life: the Israel perspective
- Top Cited Papers
- 1 October 2021
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 9 (10) , 1101-1110
Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational study
- 1 October 2021
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 9 (10) , 1101-1110
Top Cited PapersVariations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational study
- 5 April 2021
- Published by SAGE Publications in Journal of Palliative Care
- Vol. 39 (4) , 316-324
The Influence of Geography, Religion, Religiosity and Institutional Factors on Worldwide End-of-Life Care for the Critically Ill: The WELPICUS Study
Objective: To evaluate the association between provider religion and religiosity and consensus about end-of-life care and explore if geographical and institutional factors contribute to variability in practice. Methods: Using a modified Delphi method 22 end-of-life issues consisting of 35 definitions and 46 statements were evaluated in 32 countries in North America, South America, Eastern Europe, Western Europe, Asia, Australia and South Africa. A multidisciplinary, expert group from specialties treating patients at the end-of-life within each participating institution assessed the association between 7 key statements and geography, religion, religiosity and institutional factors likely influencing the development of consensus. Results: Of 3049 participants, 1366 (45%) responded. Mean age of respondents was 45 ± 9 years and 55% were females. Following 2 Delphi rounds, consensus was obtained for 77 (95%) of 81 definitions and statements. There was a significant difference in responses across geographical regions. South African and North American respondents were more likely to encourage patients to write advance directives. Fewer Eastern European and Asian respondents agreed with withdrawing life-sustaining treatments without consent of patients or surrogates. While respondent’s religion, years in practice or institution did not affect their agreement, religiosity, physician specialty and responsibility for end-of-life decisions did. Conclusions: Variability in agreement with key consensus statements about end-of-life care is related primarily to differences among providers, with provider-level variations related to differences in religiosity and specialty. Geography also plays a role in influencing some end-of-life practices. This information may help understanding ethical dilemmas and developing culturally sensitive end-of-life care strategies.
- 5 April 2021
- Published by SAGE Publications in Journal of Palliative Care
- Vol. 39 (4) , 316-324
The Influence of Geography, Religion, Religiosity and Institutional Factors on Worldwide End-of-Life Care for the Critically Ill: The WELPICUS Study
Objective: To evaluate the association between provider religion and religiosity and consensus about end-of-life care and explore if geographical and institutional factors contribute to variability in practice. Methods: Using a modified Delphi method 22 end-of-life issues consisting of 35 definitions and 46 statements were evaluated in 32 countries in North America, South America, Eastern Europe, Western Europe, Asia, Australia and South Africa. A multidisciplinary, expert group from specialties treating patients at the end-of-life within each participating institution assessed the association between 7 key statements and geography, religion, religiosity and institutional factors likely influencing the development of consensus. Results: Of 3049 participants, 1366 (45%) responded. Mean age of respondents was 45 ± 9 years and 55% were females. Following 2 Delphi rounds, consensus was obtained for 77 (95%) of 81 definitions and statements. There was a significant difference in responses across geographical regions. South African and North American respondents were more likely to encourage patients to write advance directives. Fewer Eastern European and Asian respondents agreed with withdrawing life-sustaining treatments without consent of patients or surrogates. While respondent’s religion, years in practice or institution did not affect their agreement, religiosity, physician specialty and responsibility for end-of-life decisions did. Conclusions: Variability in agreement with key consensus statements about end-of-life care is related primarily to differences among providers, with provider-level variations related to differences in religiosity and specialty. Geography also plays a role in influencing some end-of-life practices. This information may help understanding ethical dilemmas and developing culturally sensitive end-of-life care strategies.